Cancer cells can develop several strategies to evade the immune response mediated by lymphocytes. They may downregulate [antigen presentation](https://) molecules, secrete immunosuppressive factors, or express checkpoint proteins that inhibit T cell activity. This immune evasion is a significant challenge in cancer treatment.
